Small Vessel Diseases: Ultra-realistic Microstructure Computational Model to Refine Individual Treatment
University Hospital, Tours
20 participants
Mar 26, 2024
INTERVENTIONAL
Conditions
Summary
Small vessel disease (SVD) accounts for 25% of strokes and is the second most common cause of dementia after Alzheimer's disease. Unlike other causes of stroke, SVD manifests itself years before the stroke by the accumulation of tissue damage. Although heterogeneous, these lesions appear on Magnetic Resonance Imaging (MRI) as white matter hypersignals (WMH). In this context, the ANR SUMMIT project will characterize these lesions in vivo to develop new markers in the early stages of stroke. It is subdivided into 4 work packages, the third one being promoted by CHRU de Tours.
Eligibility
Inclusion Criteria1
- Prior Enrollement in Tours body donation program Age ≥ 82 years Able to remain supine in the MR scanner for acquisition (duration 60-minutes) Affiliation to social security Informed and written consent
Exclusion Criteria1
- Contraindications to body donation, especially infectious disease (VIH, HBV…) Contraindications to MRI
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
In vivo MRI
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06159140